This study is closed.
For more information on this study, visit: https://clinicaltrials.gov/ct2/show/NCT02255422
Male or female mitochondrial myopathy patients 18 through 75 years of age.
We will screen potential study participants for additional criteria.
For detailed information on qualifying for enrollment visit: https://clinicaltrials.gov/ct2/show/NCT02255422
Reata Pharmaceuticals, Inc.
Rebecca D. Considine Research Institute, 330-543-5012
Chair, NeuroDevelopmental Science Center; Philip H. Maynard Chair in NeuroDevelopmental Science Fund; Chairman, American Academy of Neurology Advocacy Committee; Pediatric Neurologist
Pediatric Brain Tumor ProgramPediatric NeurologyMitochondrial Center